Medimmune Limited

University of Helsinki

Simo Syrjala

Kari Alitalo

Ronald Herbst

Ching Ching Leow

Karl Lemstrom

Jane Connor

The disclosure is directed to methods and uses of antibodies or antigen-binding fragments thereof against Angiopoietin-2 (Ang-2). Specifically, the disclosure is direct to the use of anti-Ang2 antibodies or antigen-binding fragments thereof for treating ischemia. The methods disclosed are useful for reducing microvascular permeability, increasing microvascular perfusion, reducing inflammation in a tissue, and treating or ameliorating diseases associated with ischemia and/or reperfusion injury. The disclosed methods are also useful for protecting solid organ transplant tissue and treating or preventing chronic tissue transplant rejection.

Growing community of inventors

Helsinki, Finland

Simo Syrjala